![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 21, 2020 10:51:01 AM
All the usual wolfpack IDs became active in recent days, including the pathetic last Sunday when the usual identifiable IDs were hard in working in message board. It's a sign.
Now that Linda has shown her hand -- the multiple self-rewarded Form 4s for their hardworking of the last several years while stock price has been manipulated by short sell, and the market cap now sit at the low 250 million level.
When Linda finally showed her hand, it means the trial data is destined to be locked, and topline comes shortly in a couple of weeks if not less.
I believe the blended data today is at least as good as that we saw in 2017 and again in 2018; the likelihood of the placebo/later vaccined arm outperforms the treatment/the early vaccined arm is low based on what we have known about the disease GBM and the various failed trials and the Optune trial, etc.
Today's buying is a knowledge based risk taking mini exercise, ready for significant grabbing shares from the shorts when topline data is announced. I am pretty sure this scenario will happen as the price will still be very much suppressed then judged by some longs' knee jerking actions and too many swing traders waiting on the sideline.
Now it's action time.
[Lawyers are good when it comes to eventuality for a company. Linda and Les maybe despised for their failure to maintain/support a reasonable share price, but when all things are done, they will be much more worthy in share price, either at buyout or partnership!]
[And they will be remembered by their resolve/dexterity/"deception" to bring a "failed" trial into a hugely successful trial. No other non-lawyers run companies will success in our situations!]
[One more buying sign: the share flipping has stopped from option/warrant holders]
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM